最近,阿斯利康公司与Silence Therapeutics公司就其涵盖siRNA分子的联合研发项目签订了延长一年的合作协议。根据始于2007年7月的结盟协议,两家公司目前正在合作鉴定和优化用于呼吸系统疾病和肿瘤的5种新型siRNA治疗药物分子。而依据新的延长合作协议,阿斯利康公司仍全权负责si Recently, AstraZeneca and Silence Therapeutics signed a one-year extended cooperation agreement on a joint R & D project covering siRNA molecules. Under the alliance agreement that began in July 2007, the two companies are currently working together on the identification and optimization of five novel siRNA therapeutic drug molecules for respiratory diseases and oncology. According to the new agreement to extend cooperation, AstraZeneca is still solely responsible for si